Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab effects on [11C]docetaxel tumor kinetics in lung cancer by PET-CT
NL-OMON33463Recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jan 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of bevacizumab in bronchial carcinoma, sponsored by Vrije University Medical Center. Started Jan 2010; status: recruiting.
02
Drugs
bevacizumab
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on NL-OMON33463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33463.